Streetbeat News

Analyst Ratings

KRMD

Lake Street analyst Frank Takkinen has initiated coverage on KORU Medical Systems (NASDAQ:KRMD) with a Buy rating and a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:53 pm

NET

Cloudflare's stock is trading lower after Bank of America Securities initiated coverage on the stock with an Underperform rating.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:51 pm

BTM

Noble Capital Markets analyst Michael Kupinski has initiated coverage on Bitcoin Depot (NASDAQ:BTM) with an Outperform rating and a price target of $9.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:50 pm

BLMN

DRI

LEVI

The most accurate Wall Street analysts recommend buying three high-dividend yielding consumer stocks: Darden Restaurants, Inc. (DRI), Levi Strauss & Co. (LEVI), and Bloomin' Brands, Inc. (BLMN). These companies have been rated by analysts from Stephens & Co., Citigroup, Stifel, Guggenheim, Credit Suisse, and Barclays, with accuracy rates ranging from 70% to 76%. Recent news for these companies include upcoming financial results, margin decline and soft EPS guidance, and interest from an activist investor.

Portfolio Pulse from Lisa Levin

September 07, 2023 | 12:49 pm

SCPH

Craig-Hallum analyst Chase Knickerbocker has initiated coverage on scPharmaceuticals (NASDAQ:SCPH) with a Buy rating and a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:48 pm

ATNM

Actinium Pharmaceuticals (ATNM) presented updated survival data from its Phase 1b trial evaluating Actimab-A in combination with the salvage chemotherapy CLAG-M in patients with high-risk relapsed or refractory acute myeloid leukemia (r/r AML). The trial showed a median overall survival of 24 months in all patients and 30 months in patients who received prior venetoclax treatment. The company also presented preclinical data supporting the clinical evaluation of Actimab-A combinations with FLT3 inhibitors.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 12:48 pm

INGN

Inogen, Inc. (NASDAQ:INGN) has announced the appointment of Mike Sergesketter as Interim Chief Financial Officer, succeeding Kristin Caltrider who has stepped down for personal reasons. Sergesketter previously served as CFO of Kimball Electronics, Inc. and has over forty years of finance experience. Inogen has reaffirmed its 2023 financial guidance, expecting annual revenue of $315 million to $320 million and an Adjusted EBITDA loss of $20 million to $25 million.

Portfolio Pulse from Happy Mohamed

September 07, 2023 | 12:45 pm

BABA

FANG

UBER

XLE

On CNBC's 'Halftime Report Final Trades', Brian Belski of BMO Capital Markets recommended Uber Technologies, Stephen Weiss of Short Hills Capital Partners recommended Alibaba Group Holding, Joseph Terranova of Virtus Investment Partners recommended Diamondback Energy, and Liz Young of BNY Mellon Investment Management recommended Energy Select Sector SPDR Fund. Uber recently signed a deal with Hy-Vee for grocery delivery in the Midwest. Alibaba was reiterated with a Positive rating and a $160 price target by Susquehanna analyst Shyam Patil. Diamondback Energy's subsidiary, Viper Energy Partners, announced a purchase and sale deal to acquire certain mineral and royalty interests.

Portfolio Pulse from Lisa Levin

September 07, 2023 | 12:44 pm

VRNT

Verint Systems Inc. (NASDAQ:VRNT) reported weaker-than-expected Q2 results, with earnings of 48 cents per share and sales of $210.41 million, both below market expectations. Following the announcement, Verint shares dipped 16.8% in pre-market trading. Several analysts, including those from Needham, RBC Capital, Evercore ISI Group, and Oppenheimer, adjusted their price targets and ratings for Verint.

Portfolio Pulse from Lisa Levin

September 07, 2023 | 12:44 pm

BSET

Noble Capital Markets analyst Joe Gomes has downgraded Bassett Furniture Indus (NASDAQ:BSET) from Outperform to Market Perform.

Portfolio Pulse from Benzinga Newsdesk

September 07, 2023 | 12:42 pm